Phillip Yates, PhD

GSK, United Kingdom

Disclosure(s): GSK: Employee during conduct of this research, Stocks/Bonds

Poster(s):

• 1154 - Safety, Tolerability, and Viral Pharmacodynamics of the IgG Monoclonal Antibody Sotrovimab Administered via Intramuscular Injection for the Treatment of Early Mild-to-Moderate COVID-19
  Friday, October 21, 2022

  12:15 PM – 1:30 PM US ET